receivable has increased in line with revenue increase. Liabilities as of 31 December 2017 substantially decreased mainly from the repayment of debt owed to financial institutions. The repayment was from IPO
. Liquidity: In 2019 GC had better liquidity. Since after listed, GC had good fund from the IPO proceeds at the end of 2005 and the working capital from deposits redemption at the beginning of 2006. This caused
growth from that of Baht 543.61 million as at March 31, 2018, mainly attributable to the increases in cash form the initial public offering of new shares ( IPO) and the deposit of that cash in the form of
322.01 ลา้นบาท หรือเพิ่มข้ึนร้อยละ 22.89 เม่ือเทียบกบั ณ วนัที่ 31 ธนัวาคม 2561 ที่มีจ านวน 1,406.64 ลา้นบาท สาเหตุหลกั เน่ืองจากการ ขายหุน้เพิ่มทุน(IPO) และจากการน าเงินท่ีไดรั้บจากการขายหุน้เพิ่มทุนไปฝาก
, derived from profit for the period of 1H/2019 Baht 56 million deducted dividend paid out of Baht 44 million. Liquidity: In 2019 GC had better liquidity. Since after listed, GC had good fund from the IPO
there was no such tax benefit from IPO expense as in 2016. Financial Position : Consolidated Balance Sheet Mar. Mar. Dec % Change Mar.18- Mar.18- Unit : THB million 2018 2017 207 Mar.17 Dec.17 Cash and
the period of H1/2018 Baht 44 million deducted dividend paid out Baht 44 million. Liquidity: In 2018 GC had better liquidity. Since after listed, GC had good fund from the IPO proceeds at the end of
of Baht 454.20 million as at December 31, 2017, mainly attributable to increases by Baht 957.15 million in cash and cash equivalents which increase form IPO, Baht 18.54 million in บริษัท ดโีอด ีไบโอเทค
liquidity. Since after listed, GC had good fund from the IPO proceeds at the end of 2005 and the working capital from deposits redemption at the beginning of 2006. This caused a better working capital
การ เพิ่มข้ึนของเงินสดและรายการเทียบเท่าเงินสดจ านวน 750.71 ลา้นบาท เน่ืองจากการขายหุน้เพิ่มทุน(IPO) การเพิ่มข้ึนของ ลูกหน้ีการคา้และลูกหน้ีอื่นจ านวน 17.94 ลา้นบาท การเพิ่มข้ึนของสินคา้คงเหลือจ านวน